The Hidden Economics of Forgotten Peptides: why good drugs disappear into the void.
You’ve probably heard people frequently ask:
“If Russian peptides like Pinealon or Epithalon work so well for sleep and longevity, why were they forgotten about 40 years ago?”
“If BPC-157 healed tissue in the 90s, why was it never FDA approved?”
“Why do effective drugs disappear from mainstream medicine?”
The standard answer from doctors and people within the pharmaceutical industry is usually some variation of: “They don’t actually work,” or “There are safety concerns.”
Let me be clear: This isn’t the truth. It’s just something people say when they are too lazy to tell you the actual reason.
Drugs and peptides don’t get forgotten because they’re unsafe or ineffective.
They get forgotten because of financial incentives, corporate deprioritization, and the general economics behind drug development. This happens worldwide in Europe, the US, and the entire West.
It’s called drug capitalism.
